European venture capital (VC) deal value registered the third largest quarterly figure on record in Q2, an incredible achievement amid widespread economic uncertainty, according to data released by PitchBook.Pitchbook’s Q2 2020 European Venture Report reveals that, across Europe, investment in sectors brought to the forefront by the coronavirus pandemic such
Rochester Institute of Technology (RIT) has become the first US university to invest in Cosimo Ventures’s new, blockchain-focused tokenised fund, Cosimo X. Based in Boston and Dublin, Cosimo Ventures is an investment firm focused on deep tech companies. This is the first time that any university in the US has
TrueBridge Capital Partners has closed its sixth venture capital fund-of-funds, TrueBridge Capital Partners Fund VI, with USD600 million in capital from LPs. Investors into TrueBridge Fund VI include new and existing global LPs, including foundations and endowments, pension funds, family offices, as well as high net worth individuals. With this
Nordic life science venture fund Eir Ventures has held a first close of its new fund, that will be focusing on healthcare innovation, on EUR76 million. Eir Ventures will invest in companies with products and technologies addressing unmet medical needs and a potential to improve the life of patients. “In
Alternative Investment Fund Manager, Innvotec Limited (Innvotec), has launched a Female Ventures Fund (FVF) to invest exclusively in UK female founded or co-founded enterprises. Innvotec is also aiming to encourage more women to invest in start-ups and early stage businesses. Less than 1 per cent of VC investment goes to
Well-known Irish figures including former Taoiseach Enda Kenny, Guinness family head Lord Iveagh and U2 band members Adam Clayton and The Edge are among a wide-ranging line-up of advisors and investors in a new ‘Impact Ireland’ fund launched by Dublin-based venture private equity investor VentureWave Capital. VentureWave this week confirmed
Hoxton Ventures has held the final close of its second fund, an early stage European VC fund, which includes seed investments in Babylon Health, Deliveroo and Darktrace. Existing investors in Hoxton’s first fund have invested in the second fund as well, alongside capital from new British, Swiss and US institutional
Spanish biotech VC firm Ysios Capital has held a first close of its third fund, Ysios BioFund III, at EUR155 million. The fund has a final target size of EUR200 million. Ysios Capital is the largest venture capital firm in Spain specialised in biotechnology with EUR346 million under management through
Iron Pillar has closed its USD45 million Top Up Fund, which will top-up the Iron Pillar Fund I that held its final close in 2018 with capital commitments of USD90 million. With this new infusion of funds, Iron Pillar has added three global institutions including alternatives investor 57 Stars and
Anyfin – a Stockholm-based startup that enables consumers to refinance their existing loans, avoid high credit costs and improve their financial health – has secured USD30 million Series B round, led by EQT Ventures.Other participants in the round include existing investors; Accel, Northzone and Global Founders Capital (GFC). Dedicated to
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
